Navigation Links
2,500 Cases Completed With the Magnetic Irrigated Catheter
Date:8/5/2009

her demonstrating the potential of our remote magnetic navigation technology as a platform for all manner of cardiac and vascular interventions," said Michael P. Kaminski, Stereotaxis President and CEO. "Stereotaxis labs are quickly becoming the preferred labs for complex cases at centers across the globe. These include a growing number of community hospitals, which are using our advanced technology to build robust electrophysiology practices. With the diverse group of clinicians who now routinely use our Niobe system, we are particularly delighted that the system has maintained the safety profile for which it has become well known."

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to enable physicians to complete more complex interventional procedures by providing image guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. This is achieved using computer-controlled, externally applied magnetic fields that govern the motion of the working tip of the catheter or guidewire, resulting in improved navigation, shorter procedure time and reduced x-ray exposure. The core components of the Stereotaxis system have received regulatory clearance in the U.S., Europe, and Canada and elsewhere.

About Forward Looking Statements

This press release includes statements that may constitute "forward- looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences includ
'/>"/>

SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
2. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
3. Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions
4. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
5. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
6. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
7. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
8. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
9. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
10. New Localized Cancer Treatment for Advanced Retinoblastoma Saves Children From Having Eyes Removed, Restores Vision in Some Cases
11. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ING,Nov.24/PRNewswire-Asia-FirstCall/--LotusPharma...e"Company")agrowingdeveloperand,producerofprescrip...l,productsinthePeople,sRepublicChina,todayreported...jingpharmaceuticaldelegation. ,, Time:Novembe...nter,Chengdu ,, TheBeijingdelegationfeaturesm...
(Date:11/24/2009)...AW,Ind.,Nov.24/PRNewswire-FirstCall/--ZimmerHoldin...articipatinginthe21stAnnualPiperJaffrayHealthCareC...a.m.EasternTime. ,, Alivewebcastofthepresentati...at http://investor.zimmer.com .Thewebcastwillbearc...theCompany ,, Foundedin1927andheadquarteredinW...
(Date:11/24/2009)...IEGO,Nov.24/PRNewswire-FirstCall/--Orexigen®T...companyfocusedonthetreatmentofobesity,todayannounc...heCompany,sBoardofDirectorsgrantedaninducementstoc...onKlassen,M.D.,itsnewlyappointedHeadoftheGlobalCon...incentivestockoptiontotheextentpermittedbylawandha...
Breaking Medicine Technology:Lotus Pharmaceuticals, Inc. to Exhibit at the 62nd PHARMCHINA 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 3Work conditions impact parents food choices 9834 1Work conditions impact parents food choices 9834 2Shining a light on disease tracking light emitting bacteria during infection 56496 1California Dental Association to Showcase Critical Role of Dentists in Identifying and Treating Sleep Disorders 56492 1California Dental Association to Showcase Critical Role of Dentists in Identifying and Treating Sleep Disorders 56492 2California Dental Association to Showcase Critical Role of Dentists in Identifying and Treating Sleep Disorders 56492 3
...stic Systems, Inc. (OTC Bulletin Board: SSUR) toda...ent from Inverness Medical Innovations, Inc.,(Amex...ure and Inverness,signed two additional agreements...reby Inverness acquired an option to the exclusive...ertain infectious disease diagnostic,tests develop...
...ERN, Pa., Oct. 17 Cutanea Life Sciences, an,emerg...proving human health,and appearance through the de...diseased and aging skin conditions, today announce...al of Omiganan. The trial compared Omiganan 2.5% ...ulopustular rosacea. Study results demonstrated th...
Other Medicine Technology:StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 2StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations 3Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 2Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 3Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 4Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 5Cutanea Announces Promising Phase II Results in Rosacea with Omiganan 6
(Date:11/24/2009)...,, DALLAS,Nov.24/PRNewswire-USNewswire/--TheBay...rofoneofthelargestcancerclinicaltrialscooperativeg...heNationalCancerInstitute,SouthwestOncologyGroupco...s,andtoimprovethequalityoflifeforcancersurvivors. ...eradditional,importantclinicaltrialstocancerpatien...
(Date:11/24/2009)...,, EasterSealsNewYorkandtheNewYorkStateFraterna...hestolocalfamiliesinPortJervis,NewYork ,, PORTJ...,November23rd,EasterSealsNewYork,inpartnershipwith...ualThanksgivingOutreachatEasterSealsNewYork,sChild...r500localindividualscametotheoutreachtoreceivefree...
(Date:11/24/2009)...,, HARRISBURG,Pa.,Nov.24/PRNewswire-USNewswire/...Pennsylvaniansat-riskfortheH1N1fluwerevaccinateddu...mentofHealthandlocalhealthdepartments. ,, "With...esandprojectionsregardingtheavailabilityofH1N1vacc...ndell."Overall,wearepleasedwiththeH1N1vaccinedistr...
(Date:11/24/2009)...,, WHEATON,Ill.,Nov.24/PRNewswire-USNewswire/--...Group,hasbeennamedtherecipientoftheJamesBradyAward...ion(BIA)ofIllinoisduringtheirannualconferenceonOct...Escobarwasgiventheawardinrecognitionofhisexpertise...ies,hiscompassionatetreatmentandexceptionalcareofh...
(Date:11/24/2009)...t the herbal supplement may help ward off peripher...TUESDAY, Nov. 24 (HealthDay News) -- Among people ...loba does not prevent heart attacks, stroke or dea... that the popular herbal remedy might help prevent...rtery disease, however. , Ginkgo contains nutri...
Breaking Medicine News(10 mins):Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
...ide Dental Care to Underserved Populations, WASHI...DA) called on all concerned public agencies and pr...lfill its mission to provide,dental care to vulner...ttee on Domestic Policy, the ADA called on health,...
...edical, Inc.,(Nasdaq: ATSI ), manufacturer and ma...s and services, today announced that it will relea...ll year ended December 31,2007 after the market cl.... Pacific Time) to discuss the Company,s fourth,qu...
... unconnected cancer-promoting proteins team up to ...from the cell,s nucleus and then marking it for de...y scientists at The University of Texas M. D. Ande...ber of the forkhead family of tumor-suppressing pr...
...tate Officials Demanding Consumer Protection ...EW YORK, Feb. 14 Aetna Inc.,s decision to greatly...anesthesia agent available,to patients during canc...and Anesthesiologist Alliance (GA Alliance),welcom...
...o effects of aging, report suggests , , TH...e in the DNA of mitochondria -- the cellular power... has been found to cause degenerative heart and mu...d heart disease, similar to what can develop in hu...
...rful cellular mutation and repair processes appear...er develops, Yale School of Medicine researchers r... these findings are considerable," said David Sch...anything that compromises the function of these DN...
Other Medicine News:Health News:ADA Calls for All Stakeholders to Work Together to Help Medicaid 2Health News:ATS Medical Announces Fourth Quarter 2007 Earnings Release Date and Conference Call 2Health News:Oncoproteins double-team and destroy vital tumor-suppressor 2Health News:National Health Care Alliance Welcomes New Members 2Health News:National Health Care Alliance Welcomes New Members 3Health News:National Health Care Alliance Welcomes New Members 4Health News:Single Mutation in Mitochondrial DNA Weakens Heart, Muscles 2Health News:Yale study offers insight into possible cause of lymphoma 2
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...n advanced scientific formulation that provides po...ct Plus is based on the AREDS clinical trial, and ...g the role of lutein in eye health. Featuring low ...nt blend of antioxidant nutrients and delivers 15 ...
...is a scientifically advanced nutritional formulati...nd full body health. MacularProtect Complete is ba... research. It features a comprehensive multinutrie...ntioxidants, such as 10 mg of FloraGLO® lutein...
Oculair
Medicine Products: